首页> 外文期刊>Journal of interventional cardiology >Short- and long-term prognostic value of the TIMI risk score after primary percutaneous coronary intervention for st-segment elevation myocardial infarction
【24h】

Short- and long-term prognostic value of the TIMI risk score after primary percutaneous coronary intervention for st-segment elevation myocardial infarction

机译:原发性经皮冠状动脉介入治疗st段抬高型心肌梗死后TIMI危险评分的短期和长期预后价值

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives We investigated the short- and long-term predictive value of the TIMI risk score regarding mortality for patients treated with primary percutaneous coronary intervention (PPCI) for ST-elevation myocardial infarction (STEMI). Background Data on the long-term predictive value of the TIMI risk score is sparse. Methods We used data from 3,609 STEMI patients undergoing PPCI in a high-volume PCI center in The Netherlands. Cumulative event rates according to TIMI score variables were estimated with the Kaplan-Meier method and compared with the log-rank test. The original TIMI risk score was modified based on the availability of the data in the single center registry. Results Higher TIMI scores were associated with significantly higher mortality at short- and long-term follow-up (P < 0.001 for both). Age and Killip Class IV at presentation were significant predictors for both short- and long-term mortality. Patients with an anterior MI, heart frequence >100 beats per minute, or systolic blood pressure <100 mmHG had a worse short-term prognosis compared to those who had not. However, long-term mortality was nonsignificantly different. The presence of a history of diabetes/hypertension and weight had only long-term prognostic value. Time to PPCI did not have any prognostic value. Conclusions Our current report shows that the TIMI risk score has both short- and long-term discriminative value. The different variables contained in the TIMI risk score predict short-term prognosis, others predominantly long-term mortality, whereas some are predictive for both. (J Interven Cardiol 2013;26:8-13) ? 2012, Wiley Periodicals, Inc.
机译:目的我们调查了在经皮冠状动脉介入治疗(STEMI)升高的原发性经皮冠状动脉介入治疗(PPCI)治疗的患者中,TIMI风险评分对死亡率的短期和长期预测价值。 TIMI风险评分的长期预测价值的背景数据很少。方法我们使用了来自荷兰大容量PCI中心的3609名接受PPCI的STEMI患者的数据。根据Kaplan-Meier方法估算根据TIMI得分变量得出的累积事件发生率,并与对数秩检验进行比较。基于单个中心注册表中数据的可用性,对原始的TIMI风险评分进行了修改。结果较高的TIMI评分与短期和长期随访的死亡率显着相关(两者均P <0.001)。演讲时的年龄和基利普四级是短期和长期死亡率的重要预测因子。与没有MI的患者相比,前MI,心律> 100次/分钟或收缩压<100 mmHG的患者短期预后较差。但是,长期死亡率没有显着差异。糖尿病/高血压和体重史的存在仅具有长期预后价值。进行PPCI的时间没有任何预后价值。结论我们的最新报告显示,TIMI风险评分具有短期和长期的鉴别价值。 TIMI风险评分中包含的不同变量可预测短期预后,其他变量则主要是长期死亡率,而某些变量对两者都有预测作用。 (J介入Cardiol 2013; 26:8-13)? 2012年,Wiley Periodicals,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号